Diagnosing diabetic retinopathy

Human expert-level accuracy

Meet our client

INDUSTRYHealthcare

CUSTOMERCalifornia Healthcare Foundation

How we did it

Diagnosing diabetic retinopathy requires a skilled physician to analyze photographs of retinas. Early diagnosis enables about 90% of new cases to be controlled with proper treatment and eye monitoring.

deepsense.ai’s model reduced the time and effort needed to identify developing diabetic retinopathy.

A weighted Kappa measure based on the opinions of trained physicians was used to validate the solution. The model scored 83% QWK, a result comparable with what a skilled physician can do.

Further reading

Contact us

The administrator of the personal data provided by you in the registration form is deepsense.ai sp. z o.o., headquartered at al. Jerozolimskie 44, 00-024 Warsaw, Poland. Your personal data will be processed for the purpose of directing marketing content to you.
Detailed information about the processing of your personal data, including your rights, can be found in our privacy policy.
* This consent is required to receive email communication from deepsense.ai sp. z o.o. regarding the company and its offerings.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Locations
  • deepsense.ai, Inc.
  • 2100 Geng Road, Suite 210
  • Palo Alto, CA 94303
  • United States of America
  • deepsense.ai Sp. z o.o.
  • al. Jerozolimskie 44
  • 00-024 Warsaw
  • Poland
  • ul. Łęczycka 59
  • 85-737 Bydgoszcz
  • Poland
Let us know how we can help